Article Text
Statistics from Altmetric.com
Q In patients with moderate to severe stable asthma, does treatment with esomeprazole improve asthma outcomes?
Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ IM/Ambulatory care ★★★★★☆☆ Gastroenterology ★★★★★★☆ Respirology ★★★★★☆☆
METHODS
Design:
randomised, placebo controlled trial.
Allocation:
{concealed*}†.
Blinding:
blinded {patients, healthcare providers, data collectors, outcome assessors, data analysts, monitoring committee, and manuscript writers}†.*
Follow up period:
16 weeks.
Setting:
122 centres in North and South America and Europe.
Patients:
770 patients 18–70 years of age (mean age 45 y, 70% women) with stable, adequately treated asthma, FEV1 50–80% of predicted with ⩾12% reversibility, and mean morning peak expiratory flow (PEF) <80% predicted. Exclusion criteria included recent use of a proton pump inhibitor and recurrent moderate to severe symptoms of gastro-oesophageal reflux disease (GORD) in patients >40 years of age. During …
Linked Articles
- Glossary